topical treatments for chronic wound debridement

May 2008

See the latest information from the FDA concerning the use of unapproved topical products containing papain

We're getting questions about the differences in topical treatments for chronic wound debridement.

Dead tissue delays healing and encourages bacterial growth.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

The Vytorin controversy exposes shortcomings of surrogate endpoints
The new Auralgan is different from the older Auralgan
if generic versions of Toprol-XL and other timed-release drugs work as well as the brand
Pediatrics treating GERD in children
Gastroenterology new concerns about the safety of sodium phosphate bowel preps
Diabetes You'll hear that pioglitazone (Actos) slows atherosclerosis
Respiratory & Allergy People are hearing that Singulair might increase suicide risk
Women's Health Women often ask whether hormonal contraceptives are safe after age 35
Psychiatry You'll soon see ads for a new antidepressant called Pristiq
Psychiatry whether dementia drugs are worth using
Dermatology topical treatments for chronic wound debridement
Anticoagulants heparin recall rekindles concern over the safety of drugs made overseas